Today’s Landscape

During the past decade, convincing evidence has accumulated that conquering heart disease is not simply a matter of driving serum cholesterol down. In fact, one-half of the people who have a heart attack have normal cholesterol and now low cholesterol is being associated with a significant risk of early cognitive decline. New information is available. Clinicians are no longer limited to using antiquated measures of cholesterol, blood pressure, and blood sugars as the primary markers of increased risk for cardiometabolic disorders: advanced lipid assays, markers of oxidative stress, inflammation, hormones, and body composition are all providing new opportunities for safer and more effective early interventions to prevent and reverse cardiometabolic disease.1

IFM’s Cardiometabolic Advanced Practice Module

The module will help clinicians understand the physiology underlying cardiometabolic syndrome and cardiovascular disease, new approaches to effective assessments and treatments, and how to integrate these lifesaving tools into practice.

Benefits

  • CME credit
  • A step toward becoming an IFM Certified Practitioner
  • More than 20 live lectures (View the full schedule of topics)
  • Course Materials: PDF presentation slides, MP3 audio recordings, and MP4 video recordings of presentations (Recordings are available to download from your online account 4-6 weeks after the course concludes)
  • Pre- and post-course webinars
  • Temporary access to over 200 clinician resources that can be accessed and used in practice immediately after the course
  • IFM tools to incorporate into your practice:
    • Intake forms
    • Patient handouts
    • Assessment questionnaires
  • Healthful snacks and morning movement activities (Onsite only)
  • Question and Answer sessions with presenters
  • Networking opportunities
  • Opportunities to ask additional questions on a post-conference online forum moderated by IFM faculty


Clinical competencies to be mastered through the module:

  • Applying expanded definitions and assessment techniques to detect and classify altered body composition for identification of patients with insulin resistance and metabolic syndrome.
  • Improving patient outcomes by integrating analysis of new biomarkers linked to CVD risk factors.
  • Evaluating patient readiness for fitness programs and collaborating with patients to create easy-to-follow, effective exercise prescriptions.
  • Analyzing patient CVD risk factors using risk-calculation methods that expand upon the Framingham risk calculation approach.
  • Recognizing the role of stress in the development and progression of cardiovascular and metabolic disorders, and employing techniques to measure and mitigate the effects of stress.
  • Understand new concepts in the diagnosis and management of hypertension.
  • Applying advanced lipoprotein testing to broaden and improve the assessment of CVD risk and more sensitively guide lipid-modifying treatment plans.
  • Creating individual treatment plans using specific nutrients, phytonutrients, botanicals, pharmaceuticals, dietary plans, stress reduction techniques, and other lifestyle interventions to prevent or reverse the progression of CVD, metabolic syndrome, and type 2 diabetes.

Disclosure text is not available